137 related articles for article (PubMed ID: 22004534)
1. Radioligand binding to brain dopamine and serotonin receptors and transporters in Parkinson's disease: relation to gene polymorphisms.
Güzey C; Allard P; Brännström T; Spigset O
Int J Neurosci; 2012 Mar; 122(3):124-32. PubMed ID: 22004534
[TBL] [Abstract][Full Text] [Related]
2. Allele and genotype frequencies of serotonin and dopamine transporter and receptor polymorphisms in a Norwegian population.
Güzey C; Lopez-Rodriguez R; Myhre R; Spigset O
Genet Test Mol Biomarkers; 2011; 15(7-8):557-63. PubMed ID: 21453053
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.
Güzey C; Scordo MG; Spina E; Landsem VM; Spigset O
Eur J Clin Pharmacol; 2007 Mar; 63(3):233-41. PubMed ID: 17225991
[TBL] [Abstract][Full Text] [Related]
4. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
Vallelunga A; Flaibani R; Formento-Dojot P; Biundo R; Facchini S; Antonini A
Parkinsonism Relat Disord; 2012 May; 18(4):397-9. PubMed ID: 22113132
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography of striatal serotonin transporters in Parkinson disease.
Kerenyi L; Ricaurte GA; Schretlen DJ; McCann U; Varga J; Mathews WB; Ravert HT; Dannals RF; Hilton J; Wong DF; Szabo Z
Arch Neurol; 2003 Sep; 60(9):1223-9. PubMed ID: 12975287
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
[TBL] [Abstract][Full Text] [Related]
7. Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.
Kiferle L; Ceravolo R; Petrozzi L; Rossi C; Frosini D; Rocchi A; Siciliano G; Bonuccelli U; Murri L
Neurosci Lett; 2007 Jul; 422(3):228-31. PubMed ID: 17614196
[TBL] [Abstract][Full Text] [Related]
8. The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study.
Chavez C; Hollaus M; Scarr E; Pavey G; Gogos A; van den Buuse M
Brain Res; 2010 Mar; 1321():51-9. PubMed ID: 20079719
[TBL] [Abstract][Full Text] [Related]
9. Receptor changes in brain tissue of rats treated as neonates with capsaicin.
Zavitsanou K; Dalton VS; Wang H; Newson P; Chahl LA
J Chem Neuroanat; 2010 Jul; 39(4):248-55. PubMed ID: 20123014
[TBL] [Abstract][Full Text] [Related]
10. Genetics of impulse control disorders in Parkinson's disease.
Cormier F; Muellner J; Corvol JC
J Neural Transm (Vienna); 2013 Apr; 120(4):665-71. PubMed ID: 23232665
[TBL] [Abstract][Full Text] [Related]
11. Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
Nishimura M; Kaji R; Ohta M; Mizuta I; Kuno S
Mov Disord; 2002 Jul; 17(4):831-2. PubMed ID: 12210886
[TBL] [Abstract][Full Text] [Related]
12. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
[TBL] [Abstract][Full Text] [Related]
13. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
Paus S; Seeger G; Brecht HM; Köster J; El-Faddagh M; Nöthen MM; Klockgether T; Wüllner U
Mov Disord; 2004 Jun; 19(6):705-7. PubMed ID: 15197713
[No Abstract] [Full Text] [Related]
14. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
Nanko S; Ueki A; Hattori M; Dai XY; Sasaki T; Fukuda R; Ikeda K; Kazamatsuri H
Am J Med Genet; 1994 Dec; 54(4):361-4. PubMed ID: 7726209
[TBL] [Abstract][Full Text] [Related]
15. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
[TBL] [Abstract][Full Text] [Related]
16. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
[TBL] [Abstract][Full Text] [Related]
17. Interactions of Magnolia and Ziziphus extracts with selected central nervous system receptors.
Koetter U; Barrett M; Lacher S; Abdelrahman A; Dolnick D
J Ethnopharmacol; 2009 Jul; 124(3):421-5. PubMed ID: 19505549
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.
Farkas S; Nagy K; Jia Z; Hortobágyi T; Varrone A; Halldin C; Csiba L; Gulyás B
Brain Res; 2012 May; 1453():56-63. PubMed ID: 22480734
[TBL] [Abstract][Full Text] [Related]
19. Transitions in the transcriptome of the serotonergic and dopaminergic systems in the human brain during adolescence.
Shoval G; Bar-Shira O; Zalsman G; John Mann J; Chechik G
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1123-32. PubMed ID: 24721318
[TBL] [Abstract][Full Text] [Related]
20. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
Le Couteur DG; Leighton PW; McCann SJ; Pond Sm
Mov Disord; 1997 Sep; 12(5):760-3. PubMed ID: 9380062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
